Semi-Annual Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7734656

Concept 2017-04-01 to
2017-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
90,638,000 JPY
Cost of sales
87,836,000 JPY
Ordinary profit (loss)
-262,140,000 JPY
Gross profit (loss)
2,801,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
264,874,000 JPY
Profit (loss) before income taxes
-262,140,000 JPY
Operating profit (loss)
-262,073,000 JPY
Income taxes - current
1,647,000 JPY
Non-operating income
Non-operating income
12,000 JPY
Non-operating expenses
Non-operating expenses
80,000 JPY
Income taxes - deferred
825,000 JPY
Income taxes
2,472,000 JPY
Profit (loss)
-264,612,000 JPY
Profit (loss) attributable to non-controlling interests
-1,274,000 JPY
Profit (loss) attributable to owners of parent
-263,338,000 JPY
Comprehensive income
-264,612,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-263,338,000 JPY
Comprehensive income attributable to non-controlling interests
-1,274,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.